FAL1 regulates endothelial cell proliferation in diabetic arteriosclerosis through PTEN/AKT pathway

Eur Rev Med Pharmacol Sci. 2018 Oct;22(19):6492-6499. doi: 10.26355/eurrev_201810_16063.

Abstract

Objective: This study aims to investigate the role of FAL1 in the occurrence and progression of diabetic arteriosclerosis and its underlying mechanism.

Patients and methods: FAL1 expression in coronary artery disease (CAD) tissues, normal artery tissues, and tumor necrosis factor-α (TNF-α)-induced endothelial cells was detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). The regulatory effects of FAL1 on cell proliferation, migration, and cell cycle were examined by cell counting kit-8 (CCK-8) assay, transwell assay, and flow cytometry, respectively. Western blot was used to detect protein expressions of proliferation-related gene PCNA (proliferating cell nuclear antigen), cell cycle-related genes cyclin D1, PTEN (phosphatase and tensin homolog deleted on chromosome ten) and AKT (protein kinase B) in HUVECs. Subsequently, rescue experiments were performed to assess whether PTEN/AKT signaling pathway is activated during the process of FAL1-regulated proliferation and migration of HUVECs.

Results: FAL1 was highly expressed in CAD tissues and TNF-α-induced endothelial cells compared with that of controls. Overexpression of FAL1 in HUVECs promoted cell cycle, proliferation, and migration. FAL1 activated PTEN/AKT pathway in HUVECs, which was partially reversed by PTEN overexpression.

Conclusions: Highly expressed FAL1 can promote proliferation and migration of endothelial cells through activating PTEN/AKT signaling pathway.

MeSH terms

  • Cell Movement
  • Cell Proliferation* / drug effects
  • Cells, Cultured
  • Coronary Artery Disease / enzymology*
  • Coronary Artery Disease / genetics
  • Coronary Artery Disease / pathology
  • Diabetic Angiopathies / enzymology*
  • Diabetic Angiopathies / genetics
  • Diabetic Angiopathies / pathology
  • Disease Progression
  • Gene Expression Regulation
  • Glucose / toxicity
  • Human Umbilical Vein Endothelial Cells / drug effects
  • Human Umbilical Vein Endothelial Cells / enzymology*
  • Human Umbilical Vein Endothelial Cells / pathology
  • Humans
  • Neovascularization, Pathologic*
  • PTEN Phosphohydrolase / genetics
  • PTEN Phosphohydrolase / metabolism*
  • Plaque, Atherosclerotic
  • Proto-Oncogene Proteins c-akt / metabolism*
  • RNA, Long Noncoding / genetics
  • RNA, Long Noncoding / metabolism*
  • Signal Transduction

Substances

  • RNA, Long Noncoding
  • focally amplified long noncoding RNA on chromosome 1, human
  • Proto-Oncogene Proteins c-akt
  • PTEN Phosphohydrolase
  • PTEN protein, human
  • Glucose